#246 (Apr. 29, 2026) 'Psychedelics in Medicine: Curiosity & Caution': IMA (formerly FLCCC) Weekly Update

Could psychedelics open new doors in medicine, or are patients being asked to trust the promise before the proof is in?Sign up for weekly webinars: Weekly Webinars - Independent Medical Alliance This episode of IMA’s Weekly Show aired Wednesday, April 29, 2026.Dr. Ryan Cole, IMA Head of Medical & Scientific Affairs, sits down with Dr. Molly Rutherford, IMA Senior Fellow in Family Medicine and Addiction Medicine, to separate hope from hype around psychedelic-assisted therapies.They discuss:• Why interest in psychedelic-assisted therapies is growing now• What the current science does and does not show• Why these substances have been difficult to study• The risks of moving too quickly toward unproven treatments• What responsible progress could look like for patients, families, and physiciansThe bottom line: when a treatment changes lives, it deserves to be studied carefully, not rushed blindly.First aired 29th April 2026Also:• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization’s mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org